Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, October 30, 2013

Pharmalink Receives US Orphan Drug Designation for Busulipo

PHARMALINK RECEIVES US ORPHAN DRUG DESIGNATION FOR BUSULIPOa , ITS NOVEL ONCOLOGY PRODUCT FOR BONE MARROW TRANSPLANTATION Stockholm, Sweden - 29 October, 2013.

http://www.drugs.com/clinical_trials/pharmalink-receives-us-orphan-designation-busulipo-16279.html?
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts